跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 390 条关于
“Thriva”
全部
390
临床试验
342
药物
15
机构
6
资讯
27
去年
Thriva and Tasso Partner to Revolutionize Blood Testing for Needle Phobia Sufferers
去年
VCN-01 Receives Orphan Drug Designation from European Commission for Retinoblastoma Treatment
2年前
Viridian Therapeutics' Veligrotug Shows Promise in Phase III Thyroid Eye Disease Trial
去年
Theriva Biologics' SYN-004 Shows Positive Safety Profile in Phase 1b/2a Trial for aGVHD Prevention
去年
First-of-its-kind Gene Editing Treatment Saves Baby with Rare Genetic Disorder
去年
Viridian's Veligrotug Shows Promise in Phase 3 Trial for Chronic Thyroid Eye Disease
去年
Theriva Biologics Completes Enrollment in Phase 2b VIRAGE Trial of VCN-01 for Metastatic Pancreatic Cancer
去年
Theriva Biologics Receives FDA Guidance on Phase 3 Design for VCN-01 in Metastatic Pancreatic Cancer
2个月前
ARPA-H Launches $160 Million THRIVE Program to Advance Custom Gene Editing for Rare Diseases
7个月前
Theriva Biologics Licenses SYN-020 to Rasayana Therapeutics in $38M Deal for Gut-Targeted Therapy
第 1 页,共 3 页
上一页
下一页